Fact CheckerSign in

NCT07691424Not yet recruiting

Impact of Migration History and Social Conditions on the Immuno-virological Control of HIV in Migrants in France

Source: ClinicalTrials.gov · Last updated 8 Jul 2026

Brief summary (registry, in English)

Migrants living with HIV - whether the infection was diagnosed in their country of origin or in France- frequently experience vulnerabilities related to their migration trajectories and often face socioeconomic and administrative instability upon arrival . The primary outcome of this study is to compare the immunovirological efficacy of antiretroviral therapy among migrants living with HIV patients according to their social and administrative status.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
150 (estimated)
First submitted
2 Jul 2026
Start date
15 Jul 2026
Primary completion date
15 Feb 2029
Lead sponsor
University Hospital, Clermont-Ferrand
Diseases
HIV
NCT number
NCT07691424

What you commit to

  • Study type: Observational
  • Planned participants: 150
  • From 15 Jul 2026 to the primary completion date, 15 Feb 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Adults (≥18 years of age);
  • Migrant patients (i.e., individuals who entered France for the first time from another country) receiving care at Clermont-Ferrand University Hospital between January 1, 2010, and December 31, 2022, whose HIV infection was either known at the time of their arrival in France or diagnosed within 12 months after their arrival in France.
    • Non-inclusion Criteria:
  • Patients who declined to participate in the study;
  • Patients who do not speak French and for whom no interpretere was available
  • Adults subject to a legal protection measure (i.e., under guardianship, curatorship, or judicial protection)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Clermont-Ferrand University Hospital
Coordinator of this site? Confirm its status
Clermont-FerrandFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.